Discover HUMIRA, a biologic treatment option for adults with moderate to severe chronic plaque psoriasis (PS). See Important Safety Information & BOXED WARNING and full Prescribing Information.

May 5, 2025 · Humira (adalimumab) is a brand-name subcutaneous injection prescribed for plaque psoriasis. This article covers topics such as side effects, cost, and how Humira works.

Plaque Psoriasis: HUMIRA is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other …

Mar 24, 2025 · What is Humira? Humira (also know by its generic name adalimumab) is a TNF-alpha inhibitor biologic medication approved by the FDA in October 2005 for use in adult patients to treat …

Oct 21, 2025 · Adalimumab is used to treat plaque psoriasis, Crohn's disease, ulcerative colitis, rheumatoid arthritis, and other chronic autoimmune conditions. Compare Humira and available …

Nov 13, 2024 · Find patient medical information for Adalimumab (Humira) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Humira (also referred to by its generic name, adalimumab) is a biologic medication that is used to treat severe psoriasis and/or psoriatic arthritis. Biologics are modern medications that are made using …

Humira (adalimumab) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe psoriasis in adults.

It is approved in adults and children over 4 years of age for the treatment of psoriasis, psoriatic arthritis, polyarticular juvenile idiopathic arthritis, ankylosing spondylitis, rheumatoid arthritis, ulcerative colitis …

Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. …